This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Dr. Steven Wolk, PhD
President at Siniwali Biotechnology Solutions
Speaker

Profile

Steve is the Founder and Chief Consultant for Sinawali Biotechnology Solutions. He received his Bachelor’s degree in Chemistry from UC San Diego, where he received the Harold Urey Award, and he completed his Ph.D. work in Biophysical Chemistry at UC Berkeley under Dr. Ignacio Tinoco. A former VP in the Biotech industry, he has broad experience leading teams for Advanced Technologies, Analytical Sciences (including oligonucleotides, proteins, mRNA/LNP, polymers, and small molecules), Structural Biology, and Process Chemistry. He also has broad experience in gene editing, QC/GMP, management, as a site head, as well as developing teams, future leaders and corporate governance programs.

Agenda Sessions

  • Workshop Leaders’ Welcome and Opening Remarks

    9:00am
  • Optimizing Ex Vivo and In Vivo Applications

    11:00am
  • The Current Status Genome Editing Applications in the Clinic

    11:45am
  • Optimization and Characterization of mRNA/LNPs for Targeted Delivery in vivo

    9:30am